The Patent Finder

Recode Therapeutics, Inc.

Also on record
Records under this name other than the patents Recode Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Back to Recode Therapeutics, Inc.

PatentTitleStatus Expires Confidence
18/282,181Polynucleotide Compositions, Related Formulations, and Methods of Use Thereof
Abandoned
Abandoned Oct 18, 2026
AbandonedAbandoned Oct 18, 2026
18/282,699Polynucleotide Compositions, Related Formulations, and Methods of Use Thereof
Abandoned
Abandoned May 15, 2026
AbandonedAbandoned May 15, 2026
18/283,143Polynucleotide Compositions, Related Formulations, and Methods of Use Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/283,344Compositions and Methods for Targeted Delivery to Cells
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/283,406Compositions and Methods for Targeted Delivery to Cells
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/283,523Polynucleotide Compositions, Related Formulations, and Methods of Use Thereof
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/283,615Compositions and Methods for Targeted Systemic Delivery to Cells
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/311,274Compositions and Methods for Targeted Delivery to Cells
Abandoned
Abandoned May 15, 2026
AbandonedAbandoned May 15, 2026
18/312,305Compositions and Methods for Targeted Delivery to Cells
Abandoned
Abandoned Apr 20, 2026
AbandonedAbandoned Apr 20, 2026
18/420,141Polynucleotide Compositions, Related Formulations, and Methods of Use Thereof
Abandoned
Abandoned Apr 24, 2026
AbandonedAbandoned Apr 24, 2026
10 of 27 records shown.
Pro members see all 27.
Pro members: see all 27 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited